Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-23

Clinical Trial Update: Vagus Nerve Stimulation Titration Protocol to Improve Tolerance and Accelerate Adaptation

View source ↗

Summary

A completed clinical trial examining a titration protocol for the vagus nerve stimulator to improve tolerability and speed adaptation in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vagus nerve stimulator (VNS) system

Snippet

Sponsor: Cyberonics, Inc. | Conditions: Epilepsy, Seizures | Status: COMPLETED | Results posted: 2018-07-23